BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37741889)

  • 1. Serum Erythropoietin level in anemia of elderly with unclear etiology.
    Seong JY; Shin DY; Byun JM; Koh Y; Hong J; Kim I; Yoon SS
    Sci Rep; 2023 Sep; 13(1):15902. PubMed ID: 37741889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
    Musto P; Sanpaolo G; D'Arena G; Scalzulli PR; Matera R; Falcone A; Bodenizza C; Perla G; Carotenuto M
    Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating erythropoietin in patients with myelodysplastic syndromes.
    Jacobs A; Janowska-Wieczorek A; Caro J; Bowen DT; Lewis T
    Br J Haematol; 1989 Sep; 73(1):36-9. PubMed ID: 2803975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human erythropoietin for the treatment of anemia in the myelodysplastic syndromes: a clinical and erythrokinetic assessment.
    Verhoef GE; Zachée P; Ferrant A; Demuynck H; Selleslag D; Van Hove L; Deckers F; Boogaerts MA
    Ann Hematol; 1992 Jan; 64(1):16-21. PubMed ID: 1739754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of androgen therapy and anemia on serum erythropoietin levels in patients with aplastic anemia and myelodysplastic syndromes.
    Piedras J; Hernández G; López-Karpovitch X
    Am J Hematol; 1998 Feb; 57(2):113-8. PubMed ID: 9462542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin Levels in Elderly Patients with Anemia of Unknown Etiology.
    Gowanlock Z; Sriram S; Martin A; Xenocostas A; Lazo-Langner A
    PLoS One; 2016; 11(6):e0157279. PubMed ID: 27310832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin for the treatment of anemia of malignancy associated with neoplastic bone marrow infiltration.
    Oster W; Herrmann F; Gamm H; Zeile G; Lindemann A; Müller G; Brune T; Kraemer HP; Mertelsmann R
    J Clin Oncol; 1990 Jun; 8(6):956-62. PubMed ID: 2189957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Successful treatment of prolonged anemia after major ABO incompatible bone marrow transplantation for a case of myelodysplastic syndrome with recombinant erythropoietin].
    Koda K; Hayashi S; Ikeda K; Morita K; Tsuji Y; Takimoto R; Fujisaki Y; Nakazawa O
    Rinsho Ketsueki; 1992 Jul; 33(7):991-3. PubMed ID: 1507422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Erythropoietin treatment of anemia associated with multiple myeloma (MM) and myelodysplastic syndrome (MDS)].
    Qiao ZH
    Zhonghua Zhong Liu Za Zhi; 1993 Mar; 15(2):122-4. PubMed ID: 8223121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anemia in children with cancer is associated with decreased erythropoietic activity and not with inadequate erythropoietin production.
    Corazza F; Beguin Y; Bergmann P; André M; Ferster A; Devalck C; Fondu P; Buyse M; Sariban E
    Blood; 1998 Sep; 92(5):1793-8. PubMed ID: 9716610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of tumor necrosis factor-alpha and interferon-gamma on erythropoietin production and erythropoiesis in cancer patients with anemia].
    Wang W; Zhang MH; Yu Y; Xu CG
    Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):681-4. PubMed ID: 18399174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro stimulation of erythropoiesis by stem cell factor alone in myelodysplastic syndrome patients with elevated endogenous erythropoietin serum levels.
    Zwierzina H; Bammer T; Rollinger-Holzinger I; Herold M; Fenaux P; Nüssler V; Hoflehner E; Geissler D
    Clin Cancer Res; 1996 Jun; 2(6):1031-8. PubMed ID: 9816264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on serum erythropoietin levels in patients with hematologic malignancies].
    Han B; Shi YK; Zhu J; He XH; Lin NJ; Li SL; Shen T
    Zhonghua Xue Ye Xue Za Zhi; 2006 Aug; 27(8):543-5. PubMed ID: 17172129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum erythropoietin concentrations in patients with myelodysplastic syndromes.
    Aul C; Arning M; Runde V; Schneider W
    Leuk Res; 1991; 15(7):571-5. PubMed ID: 1861540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia.
    Landau D; London L; Bandach I; Segev Y
    PLoS One; 2018; 13(5):e0196684. PubMed ID: 29738538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A study of erythropoietin use for myelodysplastic syndrome].
    Márquez Saavedra E; Artacho Criado S
    Farm Hosp; 2004; 28(6):395-401. PubMed ID: 15628941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin treatment for chronic anemia of selected hematological malignancies and solid tumors.
    Ludwig H; Fritz E; Leitgeb C; Krainer M; Kührer I; Sagaster P; Umek H
    Ann Oncol; 1993 Feb; 4(2):161-7. PubMed ID: 8448084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous recombinant human erythropoietin for the treatment of anemia in myelodysplastic syndromes.
    Ghio R; Balleari E; Ballestrero A; Gatti AM; Mareni C; Massa G; Patrone F; Sessarego M; Timitilli S
    Acta Haematol; 1993; 90(2):58-64. PubMed ID: 8285019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of erythropoietin in patients with chronic obstructive pulmonary disease and anemia.
    Rezvani A; Masoompour SM; Azarpira N; Monjazeb R; Akbarzadeh M; Salimi M; Shahriarirad R
    Sci Rep; 2023 Apr; 13(1):6990. PubMed ID: 37117600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin response to blood loss in hemodialysis patients in blunted but preserved.
    Ross RP; McCrea JB; Besarab A
    ASAIO J; 1994; 40(3):M880-5. PubMed ID: 8555638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.